Gui‐Qi Zhu - Concepedia

Author

Gui‐Qi Zhu

Zhongshan Hospital ORCID

Also Known As

G Zhu, G. Zhu, G.‐Q. Zhu, Gengfei Zhu, Guangli Zhu, Gui-Qi Zhu, Guiqi Zhu, Gui‐Qi Zhu, Zhu, Gui-Qi

115

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Zhongshan Hospital Fudan University Sun Yat-sen University The First Affiliated Hospital, Sun Yat-sen University Wenzhou Medical University

About

Gui‐Qi Zhu is an author at Zhongshan Hospital specializing in medicine, cancer research, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	448
2	Public Health	2	2	191
3	Engineering	1	1	41
4	Health Sciences	1	1	14
5	Biostatistics	1	1	13

Gui‐Qi Zhu

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Effects of HFE C282Y and H63D Polymorphisms and Polygenic Background on Iron Stores in a Large Community Sample of Twins John B. Whitfield, Lara M. Cullen, Elizabeth C. Jazwinska, The American Journal of Human Genetics H63d PolymorphismsHfe C282yGeneticsGenetic EpidemiologyHuman Polymorphism	2000	164
The miR-561-5p/CX<sub>3</sub>CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX<sub>3</sub>CR1<sup>+</sup> Natural Killer Cells Infiltration Erbao Chen, Zheng‐Jun Zhou, Kun Xiao, Theranostics	2019	146
Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy Yujia Chen, Guan-Nan Li, Xian-Jing Li, Science Advances	2023	131
Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack Yuan Fang, Weiren Liu, Zheng Tang, Hepatology	2022	128
CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients Xiaotao Qian, Xuekun Song, Yuan He, Biomedicine & Pharmacotherapy Poor Prognostic BiomarkerBiomarker (Medicine)Prognostic BiomarkersDisease ProgressionMedicine	2015	126
Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1 Jun-Xian Du, Yihong Luo, Sijia Zhang, Journal of Experimental & Clinical Cancer Research	2021	114
Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti‐PD‐1 therapy in hepatocellular carcinoma Jialiang Cai, Lina Song, Feng Zhang, Cancer Communications	2024	110
Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle Andrew M. Penn, T. Roberts, Joanne N. Hodder, Neurology	1995	81
Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer Jie You, Gui‐Qi Zhu, Linka Xie, Oncotarget	2016	77
Association Between Sex-Specific Serum Uric Acid and Non-Alcoholic Fatty Liver Disease in Chinese Adults Shengjie Wu, Gui‐Qi Zhu, Bozhi Ye, Medicine	2015	63

Page 1